We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
-8.31%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$9.35B
AUM Growth
+$1.57B
Cap. Flow
+$2.42B
Cap. Flow %
25.92%
Top 10 Hldgs %
31.61%
Holding
370
New
10
Increased
144
Reduced
147
Closed
31

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$109M
2
MSFT icon
Microsoft
MSFT
+$108M
3
CSCO icon
Cisco
CSCO
+$104M
4
NEE icon
NextEra Energy
NEE
+$102M
5
TXN icon
Texas Instruments
TXN
+$87.5M

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$23M
2
VTR icon
Ventas
VTR
+$15.8M
3
PG icon
Procter & Gamble
PG
+$5.57M
4
ROP icon
Roper Technologies
ROP
+$4.51M
5
FAST icon
Fastenal
FAST
+$3.9M

Sector Composition

Rank Sector Weight
1 Technology 19.29%
2 Healthcare 18.06%
3 Financials 14.08%
4 Industrials 10.05%
5 Consumer Staples 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZTA icon
251
Azenta
AZTA
$1.42B
$1.01M 0.01%
38,441
-2,607
-6% -$76.2K
GBCI icon
252
Glacier Bancorp
GBCI
$6.32B
$994K 0.01%
25,083
-1,765
-7% -$75.8K
GE icon
253
GE Aerospace
GE
$389B
$981K 0.01%
27,049
-11,461
-30% -$517K
CVS icon
254
CVS Health
CVS
$123B
$973K 0.01%
14,843
-1,215
-8% -$90.7K
META icon
255
Meta Platforms (Facebook)
META
$1.5T
$963K 0.01%
7,343
-735
-9% -$106K
RTN
256
DELISTED
Raytheon Company
RTN
$950K 0.01%
6,193
-60
-1% -$10.7K
SGC icon
257
Superior Group of Companies
SGC
$225M
$947K 0.01%
53,641
-3,337
-6% -$60.5K
DHR icon
258
Danaher
DHR
$141B
$941K 0.01%
10,299
NVEC icon
259
NVE Corp
NVEC
$626M
$924K 0.01%
10,560
-9,770
-48% -$885K
CDK
260
DELISTED
CDK Global, Inc.
CDK
$920K 0.01%
19,210
+1,069
+6% +$56.4K
SLB icon
261
SLB Ltd
SLB
$76.5B
$909K 0.01%
25,185
-4,130
-14% -$204K
FLIR
262
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$909K 0.01%
20,888
-2,050
-9% -$101K
BA icon
263
Boeing
BA
$184B
$861K 0.01%
2,671
+80
+3% +$27.6K
WINA icon
264
Winmark
WINA
$1.27B
$858K 0.01%
5,395
-403
-7% -$61.7K
CSX icon
265
CSX Corp
CSX
$93.9B
$828K 0.01%
39,975
-375
-0.9% -$8.63K
EPP icon
266
iShares MSCI Pacific ex Japan ETF
EPP
$2.26B
$813K 0.01%
19,973
THO icon
267
Thor Industries
THO
$4.04B
$774K 0.01%
14,884
-787
-5% -$53.3K
CRI icon
268
Carter's
CRI
$1.48B
$770K 0.01%
9,439
-640
-6% -$58.2K
COST icon
269
Costco
COST
$421B
$768K 0.01%
3,770
+58
+2% +$13K
EXR icon
270
Extra Space Storage
EXR
$31.6B
$758K 0.01%
8,375
-355
-4% -$32.3K
HSY icon
271
Hershey
HSY
$36.8B
$746K 0.01%
6,960
-100
-1% -$10.6K
CGNX icon
272
Cognex
CGNX
$11.3B
$732K 0.01%
18,922
+12,000
+173% +$520K
HDB icon
273
HDFC Bank
HDB
$122B
$714K 0.01%
27,580
-1,980
-7% -$46.8K
CCMP
274
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$704K 0.01%
7,376
-19,034
-72% -$1.87M
TMO icon
275
Thermo Fisher Scientific
TMO
$214B
$697K 0.01%
3,115
-160
-5% -$37.5K

Similar funds

Bahl & Gaynor's Q4 2018 Portfolio in Review

As of Q4 2018, Bahl & Gaynor held 370 positions worth $9.35B, up 20% from $7.78B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor deployed $2.42B of net new capital in Q4 2018, opening 10 new positions and adding to 144 existing holdings. Its largest new stake was Celanese: 21,191 shares worth $1.91M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ventas, an estimated $15.8M trimmed.

  • Bahl & Gaynor's largest Q4 2018 buy was Celanese: 21,191 shares worth $1.91M.
  • Bahl & Gaynor added most to JPMorgan Chase in Q4 2018, an estimated $109M increase.
  • Bahl & Gaynor's biggest Q4 2018 reduction was Ventas, cutting an estimated $15.8M.
  • Bahl & Gaynor fully exited Praxair Inc in Q4 2018, selling an estimated $23M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $9.35B portfolio in Q4 2018.
  • Bahl & Gaynor opened 10 new positions and closed 31 in Q4 2018.
  • Bahl & Gaynor's portfolio value rose 20% quarter-over-quarter to $9.35B.

Based on Bahl & Gaynor's 13F filing for Q4 2018, filed 12 Feb 2019.